Pathological response to weekly nabpaclitaxel and carboplatin followed by anthracycline regimen in triple negative breast cancer – ANNALS OF ONCOLOGY, Volume 31, Supplement 6, November 2020, Page S1253 G.Sharat Chandra, M.Singhal, D.Panda, A.Sharma,S.Vala
Shortcomings of immuno oncology (IO) agents application into real-world practise due to financial constraints in a resource constrained setting - ANNALS OF ONCOLOGY, Volume 31, Supplement 7, December 2020, Page S1436. G.Sharat Chandra, M.Singhal,A.Sharma,
Real-world data of incidence of immune related toxicities with single agent immuno oncology drugs at a single center - ANNALS OF ONCOLOGY, Volume 31, Supplement 7, December 2020, Page S1439 G.Sharat Chandra, M.Singhal, D.Panda, A.Sharma,S.Valame - https:/
A Prospective Study of Response Evaluation with RCHOP Therapy in DLBCL Subtypes using Hans Algorithm - Indian J Hematol Blood Transfusion (Nov 2020) 36(Suppl 1):S1–S229. Sharat Chandra G, Pratap Kishore Das,Manish singhal, Dipanjanpanda, Atul Sharma, Shau
A real-world scenario of applicability of immuno oncology agents into practice in NSCLC in a resource constrained setting – JOURNAL OF THORACIC ONCOLOGY, Vol. 16Issue 4S767–S768Published in issue: April, 2021. G.Sharat Chandra, M.Singhal,A.Sharma, S.Valam
Primary thyroid lymphoma – A case report and its review of literature , Jan 2019 , Apollo Medicine
Oral mucositis with abiraterone acetate – a therapeutic dilemma , December 2019 , Indian journal of medical and pediatric oncology